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E-mail address: kck1@nyu.edu (K.W. Kinnally).The study of mitochondrial ion channels changed our perception of these double-wrapped organ-
elles from being just the power house of a cell to the guardian of a cell’s fate. Mitochondria commu-
nicate with the cell through these special channels. Most of the time, the message is encoded by ion
ﬂow across the mitochondrial outer and inner membranes. Potassium, sodium, calcium, protons,
nucleotides, and proteins traverse the mitochondrial membranes in an exquisitely regulated man-
ner to control a myriad of processes, from respiration and mitochondrial morphology to cell prolif-
eration and cell death. This review is an update on both well established and putative mitochondrial
channels regarding their composition, function, regulation, and therapeutic potential.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction channel), or mitochondrial porin, was the ﬁrst channel identiﬁedIon channels are central to communication within the body;
they are responsible for your thought processes and keep your
heart beating. Ion channels are the target of most pharmaceutical
products. Hence, it is not surprising that mitochondria rely heavily
on a battery of ion channels to interface the communication be-
tween the cytosol and the site of energy production, which also
holds the key to life and death decisions. Here, we will describe
the multiple channels of the outer and inner membranes of mito-
chondria that orchestrate a myriad of cellular processes from
ATP, steroid, and heme synthesis to protein import and apoptosis.
As we are electrophysiologists, we will use the single channel
behavior of these channels as our central theme.
During the 70s and 80s the notion that mitochondria might
have channels was typically dismissed because the consensus
was that mitochondria could not possibly maintain the membrane
potential and high resistance essential to oxidative phosphoryla-
tion if they had channels; opening channels would cause uncou-
pling. Historically, VDAC (voltage dependent anion-selectivechemical Societies. Published by E
tive activity; ACA, alkaline-
ucleotide translocator; CLIC,
rane anion channel; MAC,
ochondrial Centum-pico-Sie-
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et, New York, NY 10010, USA.in mitochondria. Isolated from paramecium mitochondria, VDAC’s
activity was characterized in planar bilayers in a report in 1976 by
Schein et al. [1]. Hence, the molecular identity and function of
VDAC has been known for many years. The ﬁrst characterization
of the permeability transition pore or PTP quickly followed that
of VDAC in 1979, in a series of articles by Hunter and Haworth
[2]; these were not electrophysiological, but rather based on swell-
ing assays using a photometric approach. At that time, few appre-
ciated the impact of this channel, which we now realize is central
to ischemia-reperfusion injury and necrosis. Our group and that of
Zoratti independently characterized PTP single channel behavior
10 years later by patch clamping mitoplasts, which are mitochon-
dria stripped to reveal the inner membrane [3,4]. Intriguingly,
30 years after the initial reports, the molecular identity and func-
tion of PTP remain a matter of speculation and open argument.
Nevertheless, the persistent application of patch clamping tech-
niques to mitoplasts led to the discovery of many other intriguing
channels. Sorgato ﬁrst reported the existence of a novel anion-
selective channel, mCS (mitochondrial Centum-pico-Siemen chan-
nel) in mitoplasts; the molecular identity and function of this
channel remains elusive [5]. Not much later, our lab found the
TIM23 channel, which was the ﬁrst electrophysiological demon-
stration of the link between protein import and water-ﬁlled chan-
nels in mitochondria [6]. This was quickly followed by a report
from Juin et al. on the channel activity of TOM, the protein import
complex in the outer membrane [7] (Fig. 1). And, there are numer-
ous other channels like AAA, ACA, TIM22, and various K+ channels,
which were discovered by applying these techniques to native
membranes. Here, we will provide you with an update on wherelsevier B.V. All rights reserved.
Fig. 1. The main channel activities of mitochondrial membranes. Current traces were recorded from patches excised from either reconstituted or native membranes under
symmetrical 150 mM KCl (see original articles). Pipette voltages vary from +5 to + 40 mV, but current traces are represented in the same scale for comparison. All the traces
show open channels (o) with downward transitions to sub open and closed (c) states. Traces were adapted from [100] (mouse MAC, TOM and VDAC), [101] (human TIM23 and
mCS), [60] (yeast TIM22), and [102] (mouse PTP).
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chondrial ion channels.2. The food channel, VDAC
A decade before we trained our micropipettes to chase tiny
mitochondria in suspension, VDAC conductance was reconstituted
in phospholipid bilayers [1]. A great deal of information has been
collected about this voltage dependent anion-selective channel
over the past 30 years using electrophysiological, biochemical
and functional approaches [8]. VDAC is the most abundant protein
in the outer membrane of mitochondria and it was the ﬁrst mito-
chondrial channel to be identiﬁed. While the sequence homology
is often below 30%, multiple VDAC isoforms are expressed in par-
amecium, yeast, and all higher mammalian mitochondria with
surprisingly strict functional homology. While knocking out both
isoforms of VDAC in yeast is debilitating, knocking out all three
VDAC isoforms in mouse is lethal. Hence, VDAC fulﬁlls an essen-
tial role, at least in higher organisms. Importantly and as a testa-
ment to their functional homology, expression of human VDAC in
yeast rescues the defects observed in the double knockout (re-
viewed in [9]).
VDAC provides the aqueous pathway across the outer mem-
brane for the transfer of the food from the cytosol to the inner
membrane. Hence, it is dubbed the ‘food channel’. That is, the sub-
strates, including pyruvate, malate, succinate, NADH as well as ADP
and phosphate that are used by mitochondria to generate ATP
through oxidative phosphorylation, pass through VDAC on their
way to the electron transport chain in the inner membrane. In
keeping with two way trafﬁcking, the ATP and hemes generated
by mitochondria traverse VDAC to reach the cytosol. Interestingly,
VDAC interacts with many other proteins, e.g., hexokinase and cre-
atine kinase, to trap the newly generated ATP in high energy stor-
age forms like glucose 6-phosphate and creatine phosphate, in
brain and muscle, respectively [9,10].
Bacterial porin has striking similarities to VDAC. Both channels
have b-barrel pores formed from anti-parallel b-pleated sheets.
Both channels are voltage dependent and have quite similar func-
tions in delivering foodstuffs. These similarities underlie the often
used other name for VDAC, which is mitochondrial porin. There are
however differences. For example, VDAC has a single pore and nor-
mally exists as a monomer while bacterial porins can form trimers
and adopt different conﬁgurations (reviewed in [11]).For the most part, there is a consensus that VDAC has a single
pore 2.5–3 nm wide when fully open. In its fully open state
(650 pS in 150 mM KCl) (Fig. 1), VDAC’s pore has a slight anion-
selectivity that shifts to a cation selective state when it partially
closes [12]. This shift to a half open and cation-selective state is ob-
served at both edges of VDAC’s bell-shaped voltage dependence,
i.e., at ±25–50 mV. In agreement with its dynamic gating proper-
ties, fully open VDAC allows the ﬂux of metabolites like ATP,
ADP, and Pi, along with Ca2+, K+, and Na+ across the outer mem-
brane [13]. When partially closed, the pore is 1.8 nm wide and
cation-selective. While a cationic fully open VDAC has been re-
ported, its permeability to ATP awaits further examination. There
are three mammalian isoforms of VDAC and similar single channel
behaviors are recorded using electrophysiological approaches
regardless of species. That is both rat and yeast have a fully open
state of 650 pS that are generally anion-selective with similar
voltage dependencies. In addition, both species of VDAC can as-
sume a fully open or half open state with slight cation selectivity.
VDAC structure has been deduced from NMR and crystallogra-
phy studies [14,15]. These studies agree with earlier electron
microscopy studies which report a slightly elliptical 2.7–
3.5  2.4–3.1 nm pore [16]. In the 3D models, this pore straightens
in the middle into 1.5–2.7  1–1.7 nm. These dimensions are likely
to represent those of a fully open VDAC pore. Hence, the channel
would be composed of up to 19 b-strands plus one a-helix. A con-
sensus has yet to be achieved about the role and location of this
positively charged a-helix. While the 3D models locate this N-ter-
minal helix next to the barrel’s wall, facing the c-terminus, others
suggest that this helix may be part of the barrel’s wall or perhaps
located outside in the cytoplasm. In fact, current recordings of
VDAC lacking the a-helix show smaller conductances. In a recent
opinion article, Colombini suggests that these and other discrepan-
cies regarding 3D and ‘‘functionally-derived” structures are inher-
ent to the refolding and reconstitution procedures used to obtain
the 3D structures [17]. Interestingly, and in contrast to AFM
images, the 3D structures lack superﬁcial protrusions. These pro-
trusions could be formed by the a-helix, by a b-strand, or possibly
by a putative accessory protein.
Hundreds of papers have been published on VDAC, a few hun-
dred of which show channel recordings in reconstituted systems.
However, not a single paper reports VDAC gating in the outer
membrane of isolated mitochondria that corresponds to the activ-
ity seen after reconstitution in planar bilayers or proteoliposomes.
Thus, a putative modulator that controls VDAC gating in isolated
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agreement, several cytosolic factors decreased the open probability
of VDAC reconstituted in planar bilayers. For example, NADH and
Mg2+-NAD(P)H decreases ADP ﬂux through VDAC. Moreover, an
intermembrane space (IMS) protein and tBid (a cleaved form of
Bid) has been reported as a putative endogenous inhibitor of VDAC.
Finally, VDAC can be phosphorylated and has binding sites for
hexokinase I and hexokinase II. Paradoxically, while hexokinase I
seems to close the channel, hexokinase II seems to keep it open.
The list of putative VDAC modulators is still growing – Roman
and co-workers surveyed 55 novel interactions [18]. While it is
reasonable that the most abundant protein in the mitochondrial
outer membrane might be the main pathway of communication
with the cytosol, putative modulators are based on biochemical
and electrophysiological data and also on functional studies.
Determinations of VDAC conductance and modulation of
metabolite ﬂux have just begun in intact cells. In an elegant varia-
tion of the patch clamp techniques, Jonas and co-workers showed
that a large outer membrane channel with voltage dependence
typical of VDAC can be activated in intact neurons by a train of syn-
aptic action potentials or by a cleaved form of Bcl-xL. These chan-
nels are inhibited by NADH or hypoxia [19]. Other studies include
an ethanol induced shift of cytosolic NADH/NAD+ redox potential
to a reduced state which may inhibit ADP ﬂux across the outer
membrane and a report that the conductance of VDAC is Ca2+
dependent at physiological cytosolic Ca2+ concentrations [20]. Fi-
nally, Ca2+ pretreatment of permeabilized cells enhanced subse-
quent ATP uptake, implying a VDAC-mediated regulation of
metabolism. All these studies show that the best studied mito-
chondrial channel VDAC has many faces that are just now begin-
ning to be revealed.3. Apoptosis channels
While generating the energy currency of the cell, ATP, the many
functions that mitochondria perform are just now being discov-
ered. Mitochondria play a central role in apoptosis. These organ-
elles compartmentalize a myriad of death-evoking signaling
proteins, like cytochrome c and AIF, which upon their release to
the cytosol wreak havoc and eventually induce cell death through
apoptosome formation and caspase activation. There are at least
two ways to break down the permeability barrier of the outer
membrane (Fig. 2). Activation of the inner membrane channel
PTP causes matrix swelling and ruptures the outer membrane. This
event results in a spilling of IMS contents into the cytosol. Alterna-
tively, de novo formation of a gigantic channel called MAC (mito-
chondrial apoptosis-induced channel) permits cytochrome c and
other pro-apoptotic factors to freely diffuse from the IMS to the
cytosol. Here, we discuss the channels MAC and PTP, and the
possibility these channels act synergistically in the suicide of the
cell.3.1. MAC
During apoptosis, pro-apoptotic proteins assemble into a large
channel, MAC, which makes the mitochondrial outer membrane
permeable to proteins normally constrained within the IMS. Once
in the cytoplasm, these proteins trigger a chain of events that lead
to the destruction of the cell (Fig. 2). MAC formation and mitochon-
dria outer membrane permeabilization (MOMP) have been consis-
tently reported in a variety of cell lines during at least two different
apoptotic insults, IL-3 deprivation [21] and kinase inhibition [22].
After induction of apoptosis, a time dependent increase in mem-
brane permeability resulted from formation of MACs with conduc-
tances of 3–5 nS (in 150 mM KCl) (Fig. 1). Regardless of itsheterogeneous peak conductance, >1.5 nS MAC is voltage indepen-
dent and slightly cation-selective, consistent with its proposed
function as a cytochrome c release channel (cytochrome c is cat-
ionic). MAC with a conductance of 4 nS is permeable to up to
17 kDa dextran. This polymer exclusion method indicates that
MAC with conductances between 1.5 and 5 nS have pore sizes of
2.9–7.6 nm, which should be large enough to allow the passage
of 3 nm cytochrome c. Cytochrome c in fact changes MAC conduc-
tance in an interesting way. A reversible and dose dependent in-
crease in noise and decrease in conductance (4–50%) is observed,
suggesting cytochrome c is partitioning into the pore. This effect
was named type 1 and resembles that seen with other channels,
e.g., ATP on VDAC [13,23], DNA on a-hemolysin [24], maltodextrins
on maltoporins [25], and ampicilin on OmpF [26]. The Type 2 ef-
fects of cytochrome c correspond to a more robust reduction in
conductance (50–90%) that is dose dependent, irreversible, and
voltage independent. This response corresponds either to a desta-
bilization or a plugging of the open state of MAC. Possibly, binding
sites for cytochrome c may exist in the structure of 2–4 nS MAC,
which could block the passageway and may be important in syn-
chronization of apoptotic events.
Unlike the mitochondrial protein import complexes (see be-
low), MAC allows release of soluble proteins from the IMS into
the cytosol. And, although MAC pore is at least twice as big as those
from the protein import complexes, its function is in contrast to
that of the import complexes, as this channel allows for the export
of folded proteins from mitochondria. Consistent with its function,
MAC conductance decreases in presence of cytochrome c [27], as
discussed above. Induction of MAC formation by several means,
such as staurosporine treatment, IL-3 withdrawal, exogenous
expression of Bax and tBid lead to release of cytochrome c in differ-
ent cell lines. For example, staurosporine treatment induced in-
creased expression and mitochondrial relocation of green
ﬂuorescent Bax. When mitochondria containing green ﬂuorescent
Bax where isolated and patch clamped, they showed an increase
in conductance of 6 nS, consistent with the presence of MAC.
Immunocytochemistry analysis showed cytochrome c leaked to
the cytoplasm under these conditions [22]. Such release can in turn
be prevented by knocking out Bax and Bak, overexpressing Bcl-2 or
Bcl-xL, or using MAC inhibitors [28]. The result of knocking down
MAC’s main components or its pharmacological inhibition is pre-
vention of cytochrome c release and protection against apoptosis.
Whether MAC or its components participate in other cellular
functions is of increasing interest. Some pieces of evidence exist
of a possible interaction of Bcl-2 family proteins, e.g., Bax and
Bak with the mitochondrial morphology machinery (for a review,
see [29]). Recent studies implicate Bax and Bak with maintenance
of the mitochondrial network in the absence of apoptosis, since
double knockout cells had smaller mitochondria than control cells.
While there are alternative interpretations, DDP/Timm8a, an IMS
protein that is released presumably through MAC and at the same
time as cytochrome c, can activate the ﬁssion protein Drp-1 and
promote mitochondrial fragmentation [30]. These ﬁndings support
the hypothesis that ﬁssion of mitochondria occurs after MAC for-
mation. Yet another role has been recently proposed for MAC in
generation of a so called bystander effect, based on evidence that
a death signal generated downstream of MAC and cytochrome c re-
lease seems to propagate through gap junctions to kill adjacent
cells [31].
The molecular identity of MAC, or at least most of it, has been
determined using functional knockouts, immunoprecipitations,
and pharmacological inhibitors. VDAC1 and VDAC3 have been ex-
cluded as MAC components, since MAC formation, conductance
and function were unaffected by either knockouts [32]. Neverthe-
less, two pro-apoptotic Bcl-2 members, Bax and Bak have been
established as functionally and structurally redundant core com-
Fig. 2. Mitochondrial ion channels in apoptosis. Left, Apoptotic stimuli induce relocation of Bax from the cytosol into the mitochondrial outer membrane (MOM). Bax, Bak and
possibly other unidentiﬁed protein(s) oligomerize and form MAC. An increase in ROS production, possibly due to Ca2+ entry through VDAC, MCU and mRyR, detaches
cytochrome c from cardiolipin in the inner membrane (MIM). Cytochrome c spills into the cytoplasm and binds Apaf-1 to form apoptosomes and amplify the apoptotic
cascade. Right, Necrotic stimuli lead to exacerbated Ca2+ uptake and ROS generation by mitochondria. High levels of Ca2+ and ROS induce a cyclophilin D (Cyp D)-sensitive
opening of PTP that leads to swelling of the matrix and release of Ca2+. Swelling disrupts the outer membrane while released Ca2+ activates proteases, phosphatases and
nucleases that lead to necrotic degradation.
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capable of attaining MAC conductance and releasing cytochrome
c upon apoptotic stimulation. Hence, one can envision that MAC
exists in three populations: two of them formed by Bax or Bak
homo-oligomers and one by Bax–Bak hetero-oligomers. However,
Mikhailov et al. showed that, although Bax and Bak in the oligo-
meric state are able to co-immunoprecipitate, they fail to crosslink
[33]. Hence, although Bax and Bak are unquestionable components,
their structural relationship has yet to be clariﬁed, as well as the
possible existence of additional components, for which an exten-
sive proteomic approach might be necessary.
Much of MAC structure has been deduced from functional, bio-
chemical, genetic and patch clamp studies. The pore of functional
MAC is thought to be minimally a hexamer of Bax and/or Bak
assuming each monomer contributes two transmembrane helices.
In fact, a-helices 5 and 6 of Bax are amphipatic, which makes them
good candidates for pore components [34]. Moreover, Bax lacking
helices 5 and 6 do not release cytochrome c [35,36]. Given the
structural similarities between Bax and Bak, the same helices could
underlie pore formation in MAC by either protein. Single channel
analysis of tBid-induced MAC formation in freshly isolated mito-
chondria suggested that MAC formation can be explained by
sequential incorporation of additional Bax or Bak monomers to
an existing pore [32]. However, other studies with outer mem-
brane preparations suggest a lipidic component to the pore [37].
3.2. PTP
The mitochondrial permeability transition pore (PTP) was orig-
inally described in swelling experiments on isolated mitochondria
30 years ago [2]. Opening of the PTP leads to a transition in perme-
ability of the inner membrane from extremely low to freely perme-
able to solutes up to 1.5 kDa. These changes were typically
monitored by light scattering at wavelengths known to reﬂectmitochondrial volume. The PTP can be reversibly closed by re-
moval of Ca2+ or by the addition of cyclosporine A, magnesium or
ADP. A myriad of effectors including Ca2+ plus Pi and reactive oxy-
gen species have been reported [38]. This channel has been impli-
cated in the apoptotic cascade as a means of releasing cytochrome
c from mitochondria. However, the role of PTP in early stages of
apoptosis is unclear, since its opening suspends oxidative phos-
phorylation and leads to depletion of ATP reserves required for
apoptosome formation. PTP opening is frequently observed down-
stream of MAC formation and outer membrane permeabilization,
but it is not clear if PTP has a role in induction of apoptosis. Some
models, however, advocate for a PTP dependent apoptosis prior to
MAC formation [39]. Persistent PTP opening results in loss of mito-
chondrial membrane potential and massive swelling of mitochon-
dria likely involved in necrotic cell death (Fig. 2).
The connection between the PTP and channel activities re-
corded directly from the inner membrane by patch clamping mam-
malian mitoplasts was made over a few years mostly by Zoratti’s
group [40]. In earlier studies, the PTP activity was referred to as
MCC (mitochondrial multiple conductance channel) or MMC
(mitochondrial megachannel). Although much smaller than MAC
and Bax channels, PTP has a high conductance of 1.2 nS with mul-
tiple conductance levels (Fig. 1). Transitions between sublevels are
typically 0.3–1 nS. Unlike MAC, this slightly cation-selective chan-
nel is voltage dependent, closing with matrix positive potentials.
Interestingly, while overexpression of Bcl-2 had no detectable ef-
fect on the channel activity, this protein suppressed calcium-acti-
vation of PTP in both swelling and electrophysiological
experiments [41,42]. Recently, Zoratti’s group described a new
channel activity in mitoplasts that resembles plasmalemmal
maxi-anion channels, but differs pharmacologically and was ob-
served more frequently at high Ca2+ concentrations, known to in-
duce PTP [43]. The channel conductance, gating and selectivity
rather seems closer to VDAC than PTP, although its occurrence
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cause the detection of this channel was inversely proportional to
that of PTP in ﬁve different cell lines, the authors coined this
new activity HP (Half PTP). Interestingly, HP was not affected by
cyclosporine A.
The molecular identity of PTP remains unresolved despite
extensive efforts. ANT and VDAC were thought to be pore compo-
nents of PTP based on the inhibitory effects of ANT inhibitors, and
on co-immunoprecipitation experiments of VDAC with ANT. These
candidates were later discarded because both ANT and VDAC
knockouts expressed PTP activity [44,45]. Cyclophilin D knockouts,
however, modiﬁed the permeability transition and reduced injury
after reperfusion. Knockout experiments demonstrated that cyclo-
philin D represents the target for PTP inhibition by cyclosporin A,
and that it modulates the sensitivity of the PTP to Ca2+ [46]. Re-
cently, the mitochondrial phosphate carrier was proposed as a
new candidate based on its co-immunoprecipitation with cyclo-
philin D [47]. This interaction was prevented by cyclosporin A, a
classical PTP inhibitor, and was promoted by oxidative stress, a
classical PTP inducer. However, cyclophilin D has many partners
in mitochondria. Furthermore, an essential role for the phosphate
carrier in PTP formation awaits a demonstration that knockdowns
fail to undergo a permeability transition. While the phosphate car-
rier has reported channel activity [48], assignment as the PTP
would require that the channel activity be sensitive to cyclophilin
D and cyclosporine A. Finally, as a non-protein candidate, poly-
phosphate has also proposed as the molecular basis of the PTP [49].
Studies propose alternative structural candidates in the inner
membrane, but what about the outer membrane counterpart(s)?
Most of the studies that advocated for or against VDAC participa-
tion on PTP used matrix swelling assays. This argument may be
over-interpreted because PTP is probably not the sole mediator
of matrix swelling. In fact, PTP inhibitors reduce, but do not com-
pletely abolish swelling. But the question remains. What, if one ex-
ists, is the outer membrane counterpart of PTP? If PTP really spans
both the inner and outer membranes, its conductance must be
detectable in the outer membrane of intact mitochondria. Virtually
all current traces attributed to PTP were recorded from mitoplasts,
or reconstituted systems, both devoid of the outer membrane. The
only large conductances reported to date in isolated mitochondriaFig. 3. Mitochondrial ion channels in protein import. The three major protein import
weights of subunits and arrows indicate sorting pathways of mitochondrial proteins a
components are reviewed in [54]. The three complexes rely on ion channels for protein im
TOM. In the inner membrane (MIM), Tim23 and Tim17 form the channel of TIM23, whiare attributed to MAC and depleted in Bax/Bak double knockouts
[22,32]. In summary, VDAC function (or dysfunction) can affect
ROS production and onset of PTP, but knockout studies argue
against a physical interaction and no other outer membrane pro-
tein has been associated with the permeability transition of the in-
ner membrane. In addition, the outer membrane is thought to not
represent an osmotic barrier, thus swelling is probably reliant
exclusively on yet unidentiﬁed inner membrane components.
4. Protein import channels
4.1. TOM
Only 13 of the 1500 proteins found in human mitochondria
are encoded in its genome. That means mitochondria import al-
most all of their proteins. Regardless of their ﬁnal destination, im-
ported proteins must pass through the gatekeeper, TOM, located in
the outer membrane (Fig. 3). In general, precursor proteins carry a
signal sequence in their N-terminus signal that targets them to
mitochondria. This signal can be a cysteine motif, a presequence
or an internal targeting element [50]. All these targeting sequences
are recognized by the receptor proteins Tom70 and Tom20, which
then deliver the precursor protein to Tom22. Finally, the precursor
is handed off to the translocation pore of the TOM complex. Tom40
forms the protein-conducting pore, while the small accessory pro-
teins Tom5, Tom6 and Tom7 regulate stability of the complex [50].
From this point, the general import pathway diverges into several
machines that ﬁnish the sorting and send the precursor proteins to
their ﬁnal destination. Two of these machines, TIM23 and TIM22,
have inner membrane channels that will be discussed later.
The channel activity of TOM was ﬁrst discovered in native outer
membrane preparations as a peptide sensitive channel, named
then PSC [7]. Later studies showed recombinant Tom40 was capa-
ble of forming a channel with similar characteristics in bilayer sys-
tems. Finally, comparative studies conﬁrmed those two channel
activities reﬂected the same entity, and the name PSC fell into dis-
use [51]. TOM activity has a high conductance of1 nS in yeast and
750 pS in mammals (in 150 mM KCl) (Fig. 1). A half open state is
frequently observed, especially at higher potentials. TOM activity is
sensitive to peptides whose sequences mimic that used to targetcomplexes TOM, TIM23, and TIM22 are represented. Numbers indicate molecular
ccording to their targeting sequence. The detailed pathway, additional routes and
port into mitochondria. In the outer membrane (MOM), Tom40 forms the channel of
le Tim22 forms the channel of the TIM22 complex.
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500 transitions/s.
Many structure-function studies support the channel properties
observed in patch clamp and bilayer studies. For instance, trans-
mission micrographs of negatively stained TOM show 2 or 3 pores,
consistent with the channel’s substrates. Channel ﬂickering in
presence of presequences is thought to reﬂect transient pore occlu-
sions during protein transport. Sizing with dextrans indicates that
this channel indeed has a double barrel pore. Finally, the cation
selectivity could be important for transport of positively charged
presequences. However, recent analysis of TOM conductance levels
reports up to 6 different states and suggests the double pore struc-
ture may be an oversimpliﬁed view of the channel [52].
Although TOM is considered the general import pathway to
mitochondria, its participation in transport of some outer mem-
brane proteins is still a matter of debate. For example, the insertion
of peripheral benzodiazepine receptor seems to rely exclusively on
Tom70. A similar role of Tom70 was suggested for the docking of
peripheral outer membrane proteins Mfb1 and Mcl1 to the mito-
chondrial surface. Moreover, although an involvement of the
TOM complex has been suggested for docking of pro-apoptotic
Bax, some studies suggest the opposite. Finally, the assembly of
the peripheral outer membrane protein Sam37 into the SAM com-
plex was found to occur independent of any TOM component [53].
Hence, the processes underlying the insertion of proteins contain-
ing membrane-spanning a-helices into, or association of peripher-
ally attached proteins with the outer membrane need further
investigation.
4.2. TIM23
Most of the nuclear-encoded proteins that cross TOM have the
matrix as their ﬁnal destination. These proteins carry a prese-
quence that allows their passage through TIM23, one of the protein
translocases of the inner membrane. The TIM23 complex is an
intricate machine that could contain up to 10 subunits, depending
on the ﬁnal destination of the protein in route [54]. The core com-
ponents are Tim17 and Tim23 (pore), and Tim50 (receptor), which
are sufﬁcient for recognition of precursors and the initial, mem-
brane-potential-dependent translocation of the preprotein across
the inner membrane. Tim21 reversibly interacts with the core of
TIM23 and regulates the lateral release of proteins into the inner
membrane. In absence of Tim21, the core rather interacts with
the PAM complex to allow translocation of proteins into the ma-
trix. PAM is an ATP-consuming motor formed by Pam16–18,
Pam44, Ssc1 (yeast homologue is Hsp70) and Mge1. While the
mechanism of lateral release needs more investigation, transloca-
tion into the matrix is currently better characterized. Through
ATP cleavage cycles, Mge1 assists Ssc1 to grab and pull the precur-
sor protein into the matrix. When translocation is complete, the
presequence is excised by a mitochondrial peptidase and matrix
chaperones assist in protein refolding.
Patch clamp studies in isolated mitochondria from yeast and rat
liver identiﬁed a channel whose high conductance in mitoplasts
(Fig. 1) was activated by signal peptides [6,55]. Recombinant
Tim23 showed a similar activity in bilayer systems, but signal pep-
tides were not needed for activation. Interestingly, reconstitution
of isolated inner membranes into liposomes had a similar effect,
suggesting a regulating factor present in native preparations was
lost after reconstitution. Because yeast MCC activity was depleted
or altered by Tim23 antibodies or by Tim23 mutation [6], it was
established that yeast MCC was linked to Tim23, much like PSC
and TOM and then, like PSC, the nameMCC also fell in disuse. Note,
early studies of mammalian MCC actually corresponded to record-
ings of two distinct channel activities (TIM23 and PTP), which were
later resolved by pharmacology. For example, cyclosporine Ablocks PTP, but not TIM23 channels in mammalian mitoplasts. Fur-
thermore, PTP has not yet been identiﬁed in yeast.
TIM23 activity is essentially identical to that of TOM and re-
ﬂects the cooperative and presequence-sensitive gating of twin
pores. However, recombinant Tim23 has a smaller conductance
than TIM23, suggesting additional components comprise the pore.
Indeed, mutation or knockdown of Tim17 diminish conductance. In
the case of Tim17 knock down, polymer exclusion experiments
showed the double pore was replaced by a single, presequence-
insensitive pore, incapable of protein import. Hence, Tim17 was
proposed as a component of the pore of TIM23 [56].
Although TIM23 is classically known to transport proteins into
the matrix, some studies show it could insert proteins into the in-
ner membrane by two different ways [54]. One group of inner
membrane proteins are transported into mitochondria by a conser-
vative sorting pathway that involves N-terminal presequence-dri-
ven translocation into the matrix via TIM23 and subsequent
insertion into the inner membrane from the matrix side. Another
group uses a stop-transfer mechanism for mitochondrial import
and sorting. A presequence signals translocation into the matrix
but a hydrophobic stop-transfer sequence stalls translocation,
leading to lateral release at the level of the TIM23 complex. A third
group of inner membrane proteins that use the TIM23 complex
have an internal targeting signal that is composed of a transmem-
brane domain directly followed by a presequence-like element.
Whether switching between these different transport modes in-
volves conformational changes of the complex or assembly and
disassembly processes is currently under debate.
Most of the structural and functional features currently attrib-
uted to TIM23 were obtained from yeast models, although electro-
physiological recordings were also performed in mammalian
mitoplasts. In a pioneering effort, Ahting and co-workers generated
the ﬁrst mouse knockout model of the Tim23 protein [57]. While
homozygous Tim23 mice were not viable, heterozygous F1 mu-
tants showed a 50% reduction of Tim23 protein in Western blot,
a neurological phenotype and a markedly reduced life span, under-
lying the critical role of the mitochondrial import machinery for
maintaining mitochondrial function in mammals. Electrophysio-
logical, biochemical and morphological characterization of mito-
chondria from this knockout model may reveal novel intricacies
of protein import, mitochondrial dynamics, and other essential
functions.
4.3. TIM22
Insertion of multi-topic proteins like the phosphate carrier into
the inner membrane is accomplished by the TIM22 translocase in
an energy independent manner (for a review, see [50]). This
300 kDa complex consists of the three membrane proteins
Tim22, Tim54, and Tim18 and three soluble IMS proteins, Tim9,
Tim10, and Tim12. Tim22 is the core of the complex and is related
in amino acid sequence to Tim17 and Tim23. Tim54 seems to func-
tion as a scaffold protein that would hold the complex together and
is essential for protein import [58]. Tim18 is a distant homologue
of subunit 3 of the succinate dehydrogenase, Sdh3. The precise
functions of Tim54 and Tim18 are not known and, to this date,
their presence in mammalian mitochondria has yet to be con-
ﬁrmed. A complex consisting of the small Tim subunits Tim9,
Tim10, and Tim12 is permanently tethered to the IMS side of the
TIM22 complex. Tim54 might contribute to the binding of this
Tim9–10–12 complex because its association with Tim22 was
destabilized in Tim54 deletion mutants [59]. Tim12 is an essential
protein, and the Tim9–10–12 complex may play a vital role for
substrate recognition by the TIM22 complex.
While the channel activity of TIM23 in both artiﬁcial and native
systems was identiﬁed almost concurrently, the channel activity of
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described [60]. TIM22 is a quiescent channel that requires signal
sequence interaction for its activation in both reconstituted and
native mitochondrial inner membranes. Once open, TIM22 channel
has activity remarkably similar to TIM23 and TOM, in agreement
with their purportedly analogous function at early stages of pro-
tein translocation. In reconstituted inner membrane vesicles, the
channel behavior is that of twin cooperative pores with a fully
open state of 1 nS and a 500 pS half open state (Fig. 1), much like
TIM23 and TOM. However, smaller substates are also observed in
mitoplasts.5. Mitochondrial Ca2+ channels
Mitochondrial Ca2+ channels participate in many intracellular
signaling pathways in physiological and pathological conditions
[61]. By allowing Ca2+ ﬂux in and out of mitochondria, these chan-
nels help regulate cellular bioenergetics. Importantly, inhibition of
mitochondrial Ca2+ uptake affects ADP-induced state 3 respiration
[62]. Thus, mitochondrial Ca2+ channels may allowmitochondria to
sense and coordinate changes in cytosolic energy needs. In patho-
logical conditions, however, mitochondrial Ca2+ overload contrib-
utes to the generation of reactive oxygen species [63,64], opening
of PTP [65,66], and cell death [67]. Also, dysregulation of mitochon-
drial Ca2+ handling is associated with contractile dysfunction dur-
ing heart failure [68].
Mitochondrial Ca2+ uptake has been recognized for more than
50 years – yet, its mediator(s) remains unidentiﬁed. It is often re-
ferred to as the mitochondrial calcium uniporter or MCU. Electro-
physiological and biochemical approaches indeed have yielded
many channel activities associated with the functions described
above and they seem to belong to at least six seemingly different
entities, includingMCU,MiCa, mCa1,mCa2, RaM and themitochon-
drial ryanodine receptor mRyR. However, only mRyR has been
molecularly identiﬁed and much debate exists around the idea that
the remaining ﬁve activities represent different kinetic states of
MCU. These channels and the mentioned debate are thoroughly ad-
dressed in a review on mitochondrial Ca2+ channels by Ryu et al., in
this same issue. In short, the hallmark common feature among
these Ca2+ channels is their sensitivity to nM Ru360, although
mCa2 only partially closes at 10 lM [69,70]. MCU and MiCa also
share a similar permeability to some divalent cations
(Ca2+  Sr2+Mn2+  Ba2+) and impermeability to Mg2+. However,
MiCa has a much higher Ca2+ ﬂux rate than previously reported for
MCU [69]. mCa1 and mCa2 have inward rectiﬁcation Ca2+ currents
at negative potentials like MiCa does, but mCa1 has a smaller over-
all open probability and 10-fold higher conductance, while mCa2
has a smaller conductance [70]. Finally, RaM is currently described
as a rapid kineticmode ofmitochondrial Ca2+ uptake that is inactive
at lMconcentrations and less sensitive to Ru360. At thismoment, it
is not knownwhether RaM ismediated by the samemolecular com-
plex as that of MCU.While it is possible that all these channel activ-
ities represent differentmolecular entities, differences could also be
due to experimental conditions and cell types used.
Collective efforts have been made to identify MCU over the
years. Ca2+-binding glycoproteins and ruthenium red labeled pro-
teins were isolated from mitochondria, but they remain unidenti-
ﬁed. More recently, mutagenesis and knockdown studies with
the uncoupling proteins 2 and 3 (UCP2/3) suggest they are funda-
mental for mitochondrial Ca2+ uptake [71]. However, it is not clear
yet whether or not the UCP2/3 actually form the Ca2+ conducting
pore(s) responsible for the MCU. Brookes et al. disputed this idea
by showing that neither UCP inhibitors, GDP and genipin, nor
UCP2/3 knockouts were able to alter Ca2+ uptake in normal mito-
chondria [72]. Further studies on Ca2+ currents in mitoplasts fromboth normal and UCP2/3 knockouts along with point mutations on
the putative Ca2+ conducting pore regions could be helpful to ad-
dress this issue.6. Mitochondrial K+ channels
Electrogenic mechanisms for K+ entry into mitochondria (K+
channel) have been reported for 40 years, and are thought to play
a key role in the regulation of matrix volume [73,74]. The existence
and properties of the K+ channels in mitochondria have been in-
ferred from their functional characterization. A number of channel
activities associated with K+ ﬂux through the inner membrane
were reported, but the molecular identities remain a matter of
investigation. The ﬁrst strong evidence of a channel activity was
obtained from patch clamp studies on fused giant mitoplasts from
rat liver [75]. Channel properties resembled those of the plasma
membrane cardiac KATP channel, except that the blocker
HMR1098 had a lower effect on this putative mitochondrial coun-
terpart. Another large conductance (300 pS) Ca2+ activated K+
channels found in heart and brain mitoplasts of which biophysical
characteristics are similar to plasma membrane BK channels show-
ing its inhibition by charybdotoxin and activation by NS1619
[76,77]. Finally, a margatoxin-sensitive voltage gated Kv1.3 chan-
nel was identiﬁed in T lymphocyte mitoplasts and immunodetect-
ed in mitochondria. Like other mitochondrial potassium channels,
Kv1.3 is similar in mitochondrial and plasma membranes, but the
mitochondrial membranes used lacked plasmalemmal and endo-
plasmic reticulum markers. This topic is further discussed in the
review in this same issue by Adam Szewczyk.
7. Mitochondrial anion channels
7.1. mCS
The mitochondrial Centum pico-Siemens channel, mCS, was the
ﬁrst to be identiﬁed by direct patch clamping of mitoplasts [5]. This
activity has been recorded in mitoplasts from different mammalian
tissues and species, such as mice liver, heart, brain, pancreas and
adrenal, rat liver, heart and brown adipose tissue, ox heart or
mitoplasts from human tissue culture cells, but has not been re-
ported in yeast. The channel was slightly anion-selective (PCl/
PK+ = 4.5) and showed a strong voltage dependence. At least two
closed and two open states of the same conductance were pro-
posed: a 50% sub-conductance level, as well as infrequent channel
openings 1/3 and 2/3 of the most frequent conductance level of
107 pS (Fig. 1). Additional peak conductances >140 pS in the pres-
ence amiodarone have also been reported [78]. All these conduc-
tances had the same voltage dependence, and at least the 50 pS
substate showed the same anionic selectivity. mCS was largely
unaffected by variations of pH from 6 to 9, on the matrix or cyto-
plasmic side of the membrane [5]. While Sorgato et al. recorded
the channel activity without any speciﬁc activation procedure,
we found the channel was normally quiescent but could be acti-
vated if calcium was chelated from the cytoplasmic side of mitop-
lasts during isolation procedures.
Pharmacology has enabled the elimination of a variety of pro-
teins that might underlie mCS activity. ANT was discarded because
mCS was not affected by carboxyatractylate and brongkrekate (see
below). Similarly, mCS was not associated with the F0 region of the
ATP-synthase as its activity was insensitive to oligomycin and
DCCD. Klitsch and Siemen reported that mCS was inhibited by
submillimolar levels of di- and trinucleoside phosphates, as well
as GMP, when added to the outside of patched mitoplasts [79].
These results indicated that mCS was not related to the uncoupling
protein, thermogenin, which was insensitive to GMP. Furthermore,
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lar Mg2+ or ATP and micromolar ADP was applied on the matrix
side of excised patches. Finally, the mitochondrial inner membrane
anion channel (IMAC) is a channel inferred from light scattering
(matrix swelling) studies, which had broad anion-selectivity and
conducted mono-, di-, and trivalent anions [80]. This channel is be-
lieved to be an important component of the volume homeostatic
mechanism of mitochondria, and was maintained closed or inac-
tive by matrix Mg2+ and H+. The lack of effect of Mg2+ [81], DIDS
(4,40-diisothiocyanostilbene-2,20-disulfonic acid), quinine or DCCD
[82], all of them well known blockers of IMAC, indicated this puta-
tive channel is not related to mCS.
7.2. AAA and ACA
Two other pH-sensitive channel activities were reported in liver
mitoplasts. Both of them displayed greater open probability upon
alkalinization of the matrix side of the membrane, and were acti-
vated by depletion of Mg2+ [78]. They were referred as ACA (alka-
line-induced cation-selective Activity, 15 pS) and AAA (alkaline-
induced anion-selective activity, 45 pS), respectively. AAA was ini-
tially thought to correspond to IMAC because of their similar
induction by alkaline pH or Mg2+ depletion. However, IMAC is
100-fold more selective than AAA for Cl over glucouronate.
The conductance and voltage dependence of ACA were similar to
those of the ATP-sensitive K+ channel (see above). However ACA
was insensitive to 4-aminopyridine and glibenclamide plus ATP.
The selectivity and inhibition by Mg2+ suggested that ACA channel
activity may correspond to one of the cation uniporters implicated
in volume homeostasis, whose existence was inferred from sus-
pension studies [83,84].
7.3. CLICs
Chloride intracellular channels (CLICs) represent a new class of
intracellular anion channels that have been identiﬁed by their
homology to the p64 protein. A mitochondrial homolog, mtCLIC,
has been identiﬁed from differential display analysis of differenti-
ating mouse keratinocytes from p53+/+ and p53/ mice. MtCLIC
colocalized with cytochrome oxidase in keratinocyte mitochondria
but also was detected in the cytoplasmic compartment. This p53-
regulated putative channel has been associated with apoptosis
and may exist as either a soluble or a transmembrane form that
may translocate to the nucleus in response to cell stress [85].8. Putative mitochondrial channels
Aside from mitochondrial channel activities with unresolved
identities, some studies have rather proposed putative channel
activities with known identities. Osmotic experiments in absence
and presence of Hg2+ suggested aquaporin 8 forms water channels
in mitochondria that might regulate mitochondrial shape [86]. In
this case, a channel activity has yet to be demonstrated. In other
cases, puriﬁed recombinant proteins like Bcl-2, Bcl-xL and
Omp85, a close relative of Sam50 in mammals, were capable of
forming a channel after reconstitution in lipid bilayers [87–89].
However, it is not clear if these channel activities occur in native
systems. Finally, protein free mitochondrial membrane extracts
manifested a channel activity in lipid bilayers that is attributed
to polyphosphate channels [49].9. Mitochondrial channels as therapeutic targets
Mitochondrial dysfunction is at the epicenter of many devastat-
ing diseases that increasingly affect the human population. In theUnited States alone, 1000–4000 children per year are born with a
type of mitochondrial disease. Also, many diseases of aging are
now being attributed at least to a great degree to mitochondrial
dysfunction. These include but are not limited to: Type 2 diabetes,
Parkinson’s disease, atherosclerotic heart disease, stroke, Alzhei-
mer’s disease, and cancer. Thus, mitochondria have emerged as
therapeutic targets and so have the mitochondrial ion channels,
since they are direct transducers of mitochondrial function, or dys-
function, to the rest of the cell. This section summarizes recent
studies that raise interest to some mitochondrial ion channels as
potential therapeutic targets (Table 1).
Based on the fact that VDACs are expressed more highly in can-
cer than normal cells, some studies propose VDAC-dependent cyto-
toxic agents can have cancer-selectivity. For example,
furanonaphthoquinones (FNQs) induce caspase-dependent apop-
tosis via the production of NADH-dependent reactive oxygen spe-
cies (ROS) by VDAC1. The ROS production and the anti-cancer
activity of FNQs were increased by VDAC1 overexpression [90]. An-
other drug, erastin, induces RAS-RAF-MEK-dependent non-apopto-
tic cell death via VDAC2 [91]. VDAC is also a pharmacological target
for G3139, an 18-mer phosphorothioate antisense oligonucleotide
that targets the initiation codon region of the Bcl-2 mRNA and
down-regulates the expression of Bcl-2. G3139 interacts with
and closes VDAC, inducing caspase-dependent apoptosis [92]. Fi-
nally, the plant hormone methyl jasmonate has been shown to
have selective anti-cancer activity in preclinical studies and the
mechanism seems to be through disruption of the interaction be-
tween human hexoquinase and VDAC, causing the inhibition of
glycolysis and the induction of MOMP [93].
Because MAC formation and cytochrome c release are the last
check points typically prior the activation of the caspase cascade,
these events are considered the point of no return in mitochondrial
apoptosis. For that reason, MAC is a potential target for novel ther-
apies, as the use of agonists or antagonists of this channel could in-
duce or prevent cell death, respectively. For example, agonists of
MAC could restore cytochrome c release and cell death in lympho-
mas. Some BH3 mimetic compounds like ABT-737 and its orally ac-
tive analog, ABT-263, are currently in clinical trials and could
potentially induce MAC in B-cell malignancies and myelomas
[94]. Alternatively, antagonists of MAC potentially could protect
transplanted neuronal precursor cells from apoptosis, as well as
prevent HIV-1 induced lymphocyte depletion, severe congenital
neutropenia, and other pathologies associated with Bax-induced
cytochrome c release.
Cyclosporin A, a classical PTP inhibitor has been orally adminis-
tered in a clinical study to treat Ullrich congenital muscular dystro-
phy and Bethlem myopathy patients. The mechanism of action of
this drug may be due to its binding to cyclophilin D and inhibition
of peptidyl–prolyl cis–trans isomerase activity. After a month of
treatment, muscle biopsies showed decreased apoptosis markers
and improved mitochondrial function [95]. In another disease
model, Alzheimer, an accumulation of b-amyloid in mitochondria
and its direct interaction with cyclophilin D promotes calcium-in-
duced PTP opening, suggesting this channel could also be a thera-
peutic target in this neurodegenerative disease [96].
Although disease models are available for defects in the protein
import machineries, we found no studies on therapeutic com-
pounds targeted to these machineries. Two human diseases have
been described that are caused by defects of the mitochondrial
protein import machinery: the Mohr-Tranebjaerg syndrome and
the syndrome of dilated cardiomyopathy with ataxia (DCMA).
DCMA is a type of 3-methylglutaconic aciduria, which is clinically
characterized by severe, early onset dilated cardiomyopathy,
growth retardation, ataxia and optic atrophy. It is caused by a
splice mutation in the DNAJC19 gene, which putatively corre-
sponds to the human homolog of yeast Tim14. The Mohr-Tranebj-
Table 1
Mitochondrial ion channels as therapeutic targets.
Location Type Modulators Potential role(s) Therapeutic potential
Outer membrane VDAC Bax, Bak, Bcl-xL, Bcl-2, Tom20, Ca2+,
pH, DV, NADH, DIDS
Metabolic transport,
apoptosis
FNQ, erastin, G3139, and methyl jasmonate induce
apoptosis in cancer cells through VDAC [68–71]
MAC Bax, Bak, tBid, Bcl-2, Dibucaine, TFP,
propranolol, Bci1, Bci2, iMACs
MOMP apoptosis iMACs, Bci1, Bci2 and BH3 mimetics modulate
apoptosis through MAC [22,72,81,82]
Inner membrane TIM23 Presequences, Ca2+, pH, DV, CsA Protein import Mohr-Tranebjaerg and DCMA syndromes [83–86]
PTP CsA, NIM811, bongkrekic acid, Ca2+,
pH, DV, Thiols, Bax, cyclophilin D
Necrosis, apoptosis CsA on Ullrich and Bethlem syndromes, Alzheimer,
cardioprotection [74,87]
MCU Divalent cations, nucleotides, RuRed,
Ru360, ryanodine
Ca2+ uptake, apoptosis Inhibition facilitates post reperfusion recovery [76]
MitoKATP ATP, GTP, palmitoyl CoA, Mg2+, Ca2+ Volume regulation
protection against ischemic
injury
Opening with BMS-180448 promotes cardioprotection
[75]
UCP Fatty acids Thermogenesis Overexpression protects against oxidative stress [77]
See text for details and abbreviations.
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shows X-linked recessive inheritance and is characterized by pro-
gressive sensorineural hearing loss, dystonia, mental deﬁciency,
and visual disability. It is caused by a mutation of the deafness/dys-
tonia protein1 gene (DDP1), also called translocase of the inner
membrane 8a (TIM8A).
A prototype mitoKATP channel opener, BMS-180448 [97], has
cardioprotective effects and is currently in clinical trials. However,
it also opens plasmalemmal KATP channels. The role of mitochon-
drial potassium channels in cardioprotection is a matter of debate
because of the lack of molecular identity and the ambiguous or
unspeciﬁc effects of chemical agents thought to induce or prevent
ischemia-reperfusion injuries.
Mitochondrial calcium inﬂux is an attractive target for the
treatment of reperfusion injury, based on in vitro studies with
ruthenium red. However, this compound is unsuitable for thera-
peutic use and further studies are needed to develop novel com-
pounds. One study proposed the use of dinuclear Cobalt
complexes 10 years ago, but there have been no further develop-
ments [98].
Finally, mitochondrial dysfunction is a prominent feature of
excitotoxic insult in neurons. In vitro studies have demonstrated
these events are dependent on mitochondrial Ca2+ cycling and that
a reduction in membrane potential is sufﬁcient to reduce excito-
toxic cell death. This concept has gained additional support from
experiments demonstrating that the overexpression of endoge-
nous mitochondrial uncoupling proteins (UCP), which decrease
the mitochondrial membrane potential, decreases cell death fol-
lowing oxidative stress. Thus, upregulation of UCP activity can re-
duce excitotoxic-mediated ROS production and cell death whereas
a reduction in UCP levels increases susceptibility to neuronal in-
jury. These ﬁndings raise the possibility that mitochondrial uncou-
pling could be a potential novel treatment for acute CNS injuries
[99].
10. Future perspectives
Mitochondria express a myriad of channel activities and the
function of many of these channels is not well understood. One
of the most compelling problems in this ﬁeld is lack of information
regarding the molecular basis for many of these channels. That
identiﬁcation will bring new insights into the roles channels fulﬁll
in normal and pathological conditions. Mitochondria present
technical challenges for monitoring channel activities in native
membranes which we have overcome. However, monitoring mito-
chondrial channels inside cells, e.g., using the approach of the Jonas
lab [19], or even in vivo presents additional technical challenges
especially when one considers that the outer membrane shieldsthe inner membrane from our electrodes. Nevertheless, mitochon-
drial channels are emerging as promising therapeutic targets for
many diseases like cancer, aging, neurodegenerative diseases,
stroke and infarct.
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